Literature DB >> 27826528

Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?

Silvia Calabuig-Fariñas1, Eloísa Jantus-Lewintre2, Alejandro Herreros-Pomares2, Carlos Camps3.   

Abstract

Liquid biopsies appear to be a reliable alternative to conventional biopsies that can provide both precise molecular data useful for improving the clinical management of lung cancer patients as well as a less invasive way of monitoring tumor behavior. These advances are supported by important biotechnological developments in the fields of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). Analysis of CTCs and ctDNA may be useful in treatment selection, for response monitoring, and in studying resistance mechanisms. This review focuses on the most recent technological achievements and the most relevant clinical applications for lung cancer patients in the CTC and ctDNA fields, highlighting those that are already (or are close to) being implemented in daily clinical practice.

Entities:  

Keywords:  Lung cancer, circulating tumor cell (CTC); biomarker; circulating tumor DNA (ctDNA); liquid biopsy

Year:  2016        PMID： 27826528      PMCID： PMC5099512          DOI： 10.21037/tlcr.2016.10.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


  154 in total

1.  Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

Authors:  Marco Wendel; Lyudmila Bazhenova; Rogier Boshuizen; Anand Kolatkar; Meghana Honnatti; Edward H Cho; Dena Marrinucci; Ajay Sandhu; Anthony Perricone; Patricia Thistlethwaite; Kelly Bethel; Jorge Nieva; Michel van den Heuvel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

2.  Isolation and characterization of circulating tumor cells from human gastric cancer patients.

Authors:  Dandan Yuan; Liang Chen; Mingxing Li; Hongwei Xia; Yuchen Zhang; Tie Chen; Rui Xia; Qiulin Tang; Fabao Gao; Xianming Mo; Ming Liu; Feng Bi
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-18       Impact factor: 4.553

3.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

4.  Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

Authors:  Geoffrey R Oxnard; Cloud P Paweletz; Yanan Kuang; Stacy L Mach; Allison O'Connell; Melissa M Messineo; Jason J Luke; Mohit Butaney; Paul Kirschmeier; David M Jackman; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2014-01-15       Impact factor: 12.531

5.  Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.

Authors:  Wenjun Zhou; Dalia Ercan; Liang Chen; Cai-Hong Yun; Danan Li; Marzia Capelletti; Alexis B Cortot; Lucian Chirieac; Roxana E Iacob; Robert Padera; John R Engen; Kwok-Kin Wong; Michael J Eck; Nathanael S Gray; Pasi A Jänne
Journal:  Nature       Date:  2009-12-24       Impact factor: 49.962

6.  Detection of EGFR mutations in the plasma of patients with lung adenocarcinoma for real-time monitoring of therapeutic response to tyrosine kinase inhibitors?

Authors:  Marie Marcq; Audrey Vallée; Acya Bizieux; Marc G Denis
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 15.609

Review 7.  Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer.

Authors:  Vincent Faugeroux; Emma Pailler; Nathalie Auger; Melissa Taylor; Françoise Farace
Journal:  Front Oncol       Date:  2014-11-05       Impact factor: 6.244

8.  Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors:  Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

Authors:  Kenneth S Thress; Roz Brant; T Hedley Carr; Simon Dearden; Suzanne Jenkins; Helen Brown; Tracey Hammett; Mireille Cantarini; J Carl Barrett
Journal:  Lung Cancer       Date:  2015-10-09       Impact factor: 5.705

10.  First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study.

Authors:  J-Y Douillard; G Ostoros; M Cobo; T Ciuleanu; R McCormack; A Webster; T Milenkova
Journal:  Br J Cancer       Date:  2013-11-21       Impact factor: 7.640
View more
  28 in total

1.  Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis.

Authors:  Chimbu Chinniah; Louise Aguarin; Phillip Cheng; Cristina Decesaris; Alicia Cutillo; Abigail T Berman; Melissa Frick; Abigail Doucette; Keith A Cengel; William Levin; Stephen Hahn; Jay F Dorsey; Charles B Simone; Gary D Kao
Journal:  Clin Lung Cancer       Date:  2019-05-04       Impact factor: 4.785

Review 2.  Genomics of adult and pediatric solid tumors.

Authors:  Zahraa Rahal; Farah Abdulhai; Humam Kadara; Raya Saab
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 3.  Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer.

Authors:  Mariangela Manicone; Cristina Poggiana; Antonella Facchinetti; Rita Zamarchi
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 4.  New insights in non-small-cell lung cancer: circulating tumor cells and cell-free DNA.

Authors:  Elena Duréndez-Sáez; Aitor Azkárate; Marina Meri; Silvia Calabuig-Fariñas; Cristóbal Aguilar-Gallardo; Ana Blasco; Eloisa Jantus-Lewintre; Carlos Camps
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 5.  High-dimension single-cell analysis applied to cancer.

Authors:  Lili Wang; Kenneth J Livak; Catherine J Wu
Journal:  Mol Aspects Med       Date:  2017-08-30

Review 6.  Liquid biopsy for lung cancer early detection.

Authors:  Mariacarmela Santarpia; Alessia Liguori; Alessandro D'Aveni; Niki Karachaliou; Maria Gonzalez-Cao; Maria Grazia Daffinà; Chiara Lazzari; Giuseppe Altavilla; Rafael Rosell
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

7.  Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Authors:  Zhong Ye; Chun Wang; Shaogui Wan; Zhaomei Mu; Zhenchao Zhang; Maysa M Abu-Khalaf; Frederick M Fellin; Daniel P Silver; Manish Neupane; Rebecca J Jaslow; Saveri Bhattacharya; Theodore N Tsangaris; Inna Chervoneva; Adam Berger; Laura Austin; Juan P Palazzo; Ronald E Myers; Neha Pancholy; Darayus Toorkey; Kaelan Yao; Max Krall; Xiuling Li; Xiaobing Chen; Xiuhong Fu; Jinliang Xing; Lifang Hou; Qiang Wei; Bingshan Li; Massimo Cristofanilli; Hushan Yang
Journal:  Eur J Cancer       Date:  2018-12-04       Impact factor: 9.162

Review 8.  Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients.

Authors:  Evangelia Pantazaka; Vasileios Vardas; Argyro Roumeliotou; Stavros Kakavogiannis; Galatea Kallergi
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

Review 9.  Exosomes: a new perspective in EGFR-mutated lung cancer.

Authors:  Amina Jouida; Cormac McCarthy; Aurelie Fabre; Michael P Keane
Journal:  Cancer Metastasis Rev       Date:  2021-04-14       Impact factor: 9.264

Review 10.  Roadmap on plasticity and epigenetics in cancer.

Authors:  Jasmine Foo; David Basanta; Russell C Rockne; Carly Strelez; Curran Shah; Kimya Ghaffarian; Shannon M Mumenthaler; Kelly Mitchell; Justin D Lathia; David Frankhouser; Sergio Branciamore; Ya-Huei Kuo; Guido Marcucci; Robert Vander Velde; Andriy Marusyk; Sui Huang; Kishore Hari; Mohit Kumar Jolly; Haralampos Hatzikirou; Kamrine E Poels; Mary E Spilker; Blerta Shtylla; Mark Robertson-Tessi; Alexander R A Anderson
Journal:  Phys Biol       Date:  2022-04-18       Impact factor: 2.959
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.